drugset / Trial / NCT02987907

The Impact on Therapeutic Effect and Tolerance of Treatment for Patients With Hepatocellular Carcinoma in Transcatheter Arterial Chemoembolization (TACE) of Dexamethasone Application: A Random, Double-blind, Controlled, Clinical Trial.

NCT02987907 ↗

Phase 3 Unknown 220 enrolled Sun Yat-sen University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The current random, double-blind, controlled, clinical trial was designed to evaluate the impact on therapeutic effect and tolerance of treatment for patients with hepatocelluclar carcinoma in transcatheter arterial chemoembolization (TACE) of dexamethasone application.

Timeline

Start
2016-08
Primary completion
2019-07
Completion
2019-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 10 mg Other